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Abstract: Background: The present study measured longitudinal changes in bone turnover markers in elderly patients 
with vertebral fracture and investigated the relationship among bone turnover markers, duration of bed rest and bone 
mineral density (BMD).  
Methods: Criteria for patient selection were 50 years in age and older, and presence of VF. Serum bone-specific alkaline 
phosphatase (BAP) was measured as a marker of bone formation. Urinary crosslinked N-terminal telopeptides of type I 
collagen (NTX) was measured as a marker of bone resorption. In principle, samples were collected just after injury, within 
24 h, and 1, 2, 3, 5 and 8 weeks after. We also measured duration of bed rest and BMD. 
Results: The study population consisted of 42 cases. The average BMD of the lumbar vertebrae was 0.670 ± 0.174 g/cm2. 
Bed rest period was 17.9 ± 8.8 days. BAP showed significantly higher values at 2 and 3 weeks compared with the baseline 
value. Thereafter, BAP progressively decreased until 8 weeks. Urinary NTX was increased soon after the onset of pain 
with the same patterns in BAP. Urinary NTX values reached a peak at 3 weeks, and then they kept significantly higher 
values until 8 weeks. The peak value of serum BAP was affected by the duration of bed rest, although that of the urinary 
NTX was not. The peak values of serum BAP and urinary NTX showed negative correlations with the initial BMD values. 
Conclusions: Bone turnover markers remained higher at 8 weeks, even patients symptom was healed after VF. Bone 
turnover markers were affected on physical activity and BMD. 
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  Osteoporosis is a systemic skeletal disease characterized 
by low bone mass and microarchitectural deterioration of 
bone tissue, with a consequent increase in bone fragility and 
susceptibility to fracture [1]. Vertebral fractures (VF) are the 
classic hallmark of osteoporosis [2]. 
  Generally, it is thought that bone loss accelerates with 
high turnover of the bone after menopause. This accelerated 
turnover declines over time until a steady state of low 
turnover is eventually reached. Further, some studies have 
indicated that there is high turnover in the early 
postmenopausal period that decreases through the seventh 
and eighth decade, over 15 years after menopause [3, 4]. 
Recently, we reported that bone turnover markers associated 
with back pain (BP) are significantly increased in elderly 
women, and speculated that these bone turnover markers are 
increased by unrecognized VF in patients with BP [5]. 
  Several clinical studies have pointed out that bone 
turnover markers after fractures increase with fracture   
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healing [6-15]. Usually, VF requires prolonged bed rest for 
pain relief. Bone resorption markers are strongly related to 
physical activity [16-20]. Therefore, VF or low physical 
activity such as bed rest might differently influence bone 
turnover markers. However, there have been no reports 
regarding the relationship between bed rest after VF and 
bone turnover markers. Longitudinal and prospective studies 
are desirable to elucidate the time course of changes in bone 
turnover markers in elderly women and the precise 
relationships between bone turnover markers, BP, and VF. 
  In our institute, elderly patients with severe BP were 
evaluated using radiograph (X-P), magnetic resonance imaging 
(MRI) and bone scintigram (BS). Many of these patients were 
diagnosed as having VF and were treated with bed rest [21]. 
The present study monitored longitudinal changes in bone 
turnover markers in elderly patients with VF and investigated 
the relationship among bone turnover markers, duration of bed 
rest, and bone mineral density (BMD). 
MATERIALS AND METHODOLOGY 
Patients 
  Criteria for patient selection were 50 years of age and 
older and the presence of osteoporotic VF with or without a Early Changes in Bone Specific Turnover Markers  The Open Orthopaedics Journal, 2011, Volume 5    33 
history of minor trauma. Patients with high-energy injuries 
were excluded from this study. Forty-two consecutive 
patients with VF combined with osteoporosis were admitted 
to our institution because of severe pain when changing 
positions and inability to sit up. All the patients gave 
informed consent for examination and medical treatment. 
This study was carried in accordance with the Declaration of 
Helsinki. The study was approved by the Ethics Committee 
of Suwa Red Cross Hospital. The authors report no conflicts 
of interest. The authors alone are responsible for the content 
and writing of the paper. 
Radiologic Evaluation 
  Patients underwent a series of imaging studies including 
anterior-posterior (AP) and lateral X-P, MRI of the spine, 
and BS within one week after admission. 
  Diagnosis of VF on MRI was made when T1-weighted 
images showed low intensity images in the involved vertebra 
on the sagittal plane and intense radiotracer uptake on BS. In 
addition, BMD of the AP lumbar spine was measured using 
dual X-ray absorptiometry (DXA) (QDR2000 Hologic, 
Waltham, MA, USA) for unaffected vertebra. 
  The final diagnosis of VF was based on radiographic 
findings on MRI and BS, and the clinical course of the 
patient. 
Treatment of Osteoporotic VF 
  Patients were treated conservatively with bed rest until 
severe BP had diminished and patients could sit up with 
mild, tolerable BP. The duration of bed rest was defined as 
the period from the onset of VF to the time patients could 
ambulate with external fixation by orthosis or plaster cast. 
During this period, the patients were allowed to raise in bed 
if doing so without pain. Patients who could sit up with no 
pain were allowed to walk with external fixation by orthosis 
or plaster cast. 
Biochemical Markers 
  Serum bone-specific alkaline phosphatase (BAP) was 
measured as a marker of bone formation. Urinary level of 
cross-linked N-terminal telopeptides of type I collagen 
(NTX) was measured as a marker of bone resorption by 
enzyme-linked immunosorbent assay (ELISA). In principle, 
samples of venous blood and spot urine were collected six 
times as closely as possible in accordance with the following 
schedule: just after, within 24 h, and 1, 2, 3, 5, and 8 weeks 
after injury. Patients were encouraged to undergo 
measurements more than four times. Second spot urine 
samples were collected in the morning, to avoid first 
morning urine. The samples were stored at -20°C until 
analysis. The immunoassay was performed by SRL Inc. 
(Tokyo, Japan). 
Statistical Analysis 
  The results are expressed as the means and standard 
deviation (SD). Differences in the levels of bone turnover 
markers between at the onset of BP and at each examination 
point were assessed using Student’s unpaired t-test. 
Significance was accepted at a p-value of less than 0.05. The 
correlations between bone turnover markers and period of 
bed rest or BMD were assessed using Pearson’s correlation 
coefficient. 
RESULTS 
  The study population consisted of 42 cases, 28 women 
and 14 men, ranging in age from 57 to 95 years (mean, 77.7 
years). The average BMD of the lumbar vertebrae was 0.670 
± 0.174 g/cm
2 (Table 1). Bed rest period was 17.9 ± 8.8 days 
for patients with VF. All patients showed a low T1-weighted 
signal of the affected vertebr on MRI and intense 
radiotracer uptake on BS. All patients demonstrated a 
decrease in BP with conservative treatment. 
Table 1.  Characteristics of patients 
 
Characteristics  Number or Mean ± SD (Range) 
Male sex (Female)  14 (28)   
Age (years)  77.7 ± 8.2  (57-95) 
Weight (kg)  51.0 ± 9.7  (35-75) 
Height (cm)  154.7 ± 7.3  (140-173) 
Lumbar spine BMD  0.670 ± 0.174  (1.073-0.409) 
 
The Time Course of Serum BAP Value (Fig. 1) 
  BAP was 31.8 ± 14.3 U/l at the baseline, which quickly 
increased toreach 45.4 ± 14.1 U/l at 3 weeks after the onset 
of BP, showing significantly higher values at 2 and 3 weeks 
compared with the baseline value. Thereafter, BAP 
decreased to 38.3 ± 15.2 U/l at 8 weeks. Although the 
difference was not significant compared to the baseline 
value, BAP continued to show slightly higher values until 
the 8th week. 
The Time Course of Urinary NTX Value (Fig. 2) 
  Urinary NTX was increased soon after the onset of BP, 
with the same patterns as for BAP. At 2 weeks after the 
onset of BP, urinary NTX rose from 73.2 ± 52.4to 131.3 ± 
77.9 nmol BCE / mmol Cr. Urinary NTX reached a peak at 3 
weeks, and then maintained significantly higher values 
compared with the baseline until the 8th week. Both serum 
BAP and urinary NTX reached peak values 3 weeks after 
trauma, suggesting bone formation and resorption increase 
after fracture. 
Effects of BMD and Bed Rest Period on Biochemical 
Markers 
  In these patients, the relation between the peak values of 
bone turnover markers, the duration of bed rest, and BMD 
were examined. There was no correlation between BMD and 
bed rest period. The peak value of BAP, however, had weak 
correlation with the duration of bed rest (Fig. 3): as the rest 
period became longer, the BAP value became significantly 
lower. In contrast, the peak value of urinary NTX did not 
correlate with the duration of bed rest (Fig. 4). 
  The peak values of both serum BAP and urinary NTX 
showed negative correlation with the BMD value at the onset 
of BP (Figs. 5, 6). 
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DISCUSSION 
  VF is a common osteoporotic fracture in elderly patients, 
and the incidence of VF has increased in recent years. In 
patients with osteoporosis, VF frequently causes BP [21-23]. 
As BP usually ceases within a few weeks, these fractures are 
not considered to induce severe clinical problems in most   
 
cases [24]. Furthermore, Vogt et al. reported that the 
fractures are recognized and diagnosed in only one third of 
patients with VF [25]. However, regardless of the presence 
of trauma, severe BP in patients with osteoporosis tended to 
indicate the presence of VF [21]. In patients with 
osteoporosis, VF causing severe BP requires a prolonged bed 
rest period for pain relief regardless of traumatic episode 
 
Fig. (1). Baseline values and longitudinal absolute mean value (±SD) of serum BAP. 
 
Fig. (2). Baseline values and longitudinal absolute mean value (±SD) of urinary NTX. 
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and/or vertebral deformity. Osteoporotic VF demonstrates 
various interesting clinical features, and such fractures may 
variously influence bone turnover markers. 
  Various biochemical markers reflect bone metabolism. 
When bone resorption occurs, breakdown products of type I 
collagen are released into the circulatory system. NTX is one 
of these breakdown products and the urinary NTX level has 
been reported to be a specific and sensitive marker of bone 
resorption [26]. BAP is a specific product of osteoblasts and 
is used as a typical bone formation marker to evaluate bone 
turnover. In the present study it was shown that both bone 
formation and resorption markers increased over 8 weeks 
after fracture. 
 
 
Figs. (3, 4). It is not correlation between NTX, but correlation 
between NTX and duration of bed rest. 
  Many authors have reported that bone turnover markers 
increased after fractures [6-15]. For example, hip fracture is one 
of the most common fractures in osteoporotic patients, 
comprising mainly femoral trochanter and neck fracture. 
Despite differences in post-operative therapy, the change of 
bone turnover markers during the healing of these fractures 
showed a similar pattern [13, 27]. However, the increase of 
bone turnover markers was significantly greater in trochanter 
fracture than in neck fracture, indicating that each type of 
fracture showed a different amount of influence on bone 
turnover markers. 
  In this study, patients with osteoporotic VF showed a 
tendency toward a negative correlation between bone turnover 
markers and BMD. It was suspected that mechanical force 
caused a larger area of vertebral body destruction for the 
patients with lower BMD, resulting in stronger effect on the 
bone turnover markers. 
  Generally, it is considered that the fracture may have a direct 
impact on bone formation and immobilization following 
fracture may induce an increase in bone resorption [7]. 
According to the previous studies, bone resorption markers are 
strongly related to physical activity [16-20]. In fact, some 
authors have found that bone resorption markers were increased 
[16-20] while bone formation markers decreased with bed rest 
[17]. Therefore, decreased physical activity such as bed rest 
usually causes an increase in bone resorption and an inhibition 
of bone formation. However, there are no reports describing 
changes in bone turnover marker due to osteoporotic VF with 
consideration for the duration of bed rest. 
 
 
Figs. (5, 6). There was a correlation between BAP and BMD, as well as 
a correlation between NTX and BMD. 
  The present study demonstrated that the peak value of bone 
formation marker correlated with the duration of bed rest, while 
the peak value of bone resorption marker did not. It was 
considered that these correlations of bone formation marker 
were influenced by mechanical load to VF or physical activity. 
During fracture healing, acceleration of bone fusion might 
increase both bone formation and resorption markers. However, 
long-term bed rest accelerated bone resorption and decreased 
bone formation. For these reasons, it was speculated that early 
mobilization of patients increases mechanical load of VF before 
healing, accelerating the fracture healing process and increasing 
bone formation. Another possible reason is that long-term bed 
rest induces greater decline in bone formation; however it must 
be emphasized that the level is not significant, and further 
research is required. 
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  This study has some limitations. First, the study was not 
population-based and the sample size was not large enough to 
draw definite conclusions. Second, not all data was collected in 
each period, and therefore time course of bone turnover markers 
might not be accurately reflected. 
  Recently, many studies have shown that an increase in bone 
turnover after menopause persists for longer than was 
previously believed. An increased incidence of fractures with 
aging has been demonstrated [28, 29]. Women aged over 80 
years frequently have VF and the presence of such fractures is a 
strong risk factor for subsequent fractures [21, 25, 30, 31]. We 
previously reported that NTX and BAP levels were increased 
significantly in women over 80 years compared to those at age 
60, and specifically in patients with BP associated with 
unrecognized fracture [5]. Considering these findings, elderly 
women with osteoporosis might show repeated VF regardless of 
symptoms such as BP, and VF might obviously affect the level 
of bone turnover markers. Therefore, in elderly patients with 
osteoporosis, bone turnover markers may be unstable. 
CONCLUSION 
  Bone turnover markers remained higher at 8 weeks, even in 
patients for whom symptoms had ceased after VF. Bone 
turnover markers were likely to be affected by physical activity 
and BMD. An increase in bone turnover markers after vertebral 
fracture and the subsequent decrease may reflect bone formation 
and remodeling during the fracture healing process. High 
turnover may reflect not only bone fragility but also fracture 
healing. 
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